Sperm, Exposure and Endocrine Disruptors
Condition(s) studied
Investigational drug(s) / intervention(s)
EDC Education Intervention: Participants receive a 14 module intervention program about endocrine disrupting chemicals and reducing exposures. Participants must complete at least 8 modules over the course of 8 weeks.
Study summary
The proposed research aims to 1) measure male participants' urinary levels of EDCs and sperm quality before and after report-back and EDC reduction intervention and assess changes, 2) assess the extent to which MM's program (testing, curriculum, and report-back) alters participant environmental health literacy (EHL), readiness to change (RtC), and product/lifestyle choices, and 3) test the feasibility and acceptability of MM's program to male participants. The primary study subjects are adult men of reproductive age. The study aims to have 60 participants complete the study.
Eligibility
Primary outcome measure(s)
- Change in Environmental Health Literacy — 12-weeks
This surveys assesses EDC-specific environmental health literacy, based on questions in a 5-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) or 1 (never) to 5 (always). Responses will be reverse coded during analysis as needed so that higher numbers reflect positive outcomes (higher EDC-EHL). - Change in Sperm Count — 12 Weeks
Changes measured from Fellow Sperm Test- total motile count at the baseline and post intervention. - Change in Readiness to Change — 12 weeks
The Readiness to Change question asks participants to choose the response (sentence) that most accurately describes their current efforts and interest in limiting their exposure to harmful chemicals. Responses will be coded from 1 to 5 with 5 reflecting greater readiness to reduce risky behaviors. - Change in Metabolites — 12 weeks
Urinary EDC metabolites include bisphenols, phthalates, parabens and oxybenzone.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Million Marker Wellness Inc. | Berkeley | California |
More Million Marker Wellness, Inc. trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07703046 on ClinicalTrials.gov ↗ ← All trials in the USA